CASPER PHARMA LLC FDA Approval NDA 061015

NDA 061015

CASPER PHARMA LLC

FDA Drug Application

Application #061015

Application Sponsors

NDA 061015CASPER PHARMA LLC

Marketing Status

Discontinued001

Application Products

001OINTMENT;OPHTHALMICEQ 5MG BASE/GM;10,000 UNITS/GM0TERRAMYCIN W/ POLYMYXIN B SULFATEOXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE

FDA Submissions

ORIG1AP1965-07-08
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1998-02-06
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1999-04-01
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1999-04-01
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2000-03-22
LABELING; LabelingSUPPL6AP2004-10-25

Submissions Property Types

SUPPL1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0

CDER Filings

CASPER PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 61015
            [companyName] => CASPER PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TERRAMYCIN W\/ POLYMYXIN B SULFATE","activeIngredients":"OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE","strength":"EQ 5MG BASE\/GM;10,000 UNITS\/GM","dosageForm":"OINTMENT;OPHTHALMIC","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"TERRAMYCIN W\/ POLYMYXIN B SULFATE","submission":"OXYTETRACYCLINE HYDROCHLORIDE; POLYMYXIN B SULFATE","actionType":"EQ 5MG BASE\/GM;10,000 UNITS\/GM","submissionClassification":"OINTMENT;OPHTHALMIC","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.